The Wuhan Institute of Virology has developed a new nasal Covid-19 vaccine intended to offer extensive protection against ...

Broad spectrum’ nanovaccine can target multiple coronaviruses, says team at institute once in spotlight over Covid lab leak ...

Research led by scientists at La Jolla Institute for Immunology (LJI) suggests that many people already have immune cells on ...

For the past several years, millions of birds around the world have been killed or culled because of a highly pathogenic form ...

A team of researchers at the Wuhan lab has claimed that combining Covid epitopes (antigens that trigger the human immune system) along with ferritin (blood protein) could develop an intranasal ...

A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in ...

By Tarun Sai Lomte Even after two years, individuals with long COVID display resilient immune responses, offering hope for ...

An antibody developed by researchers works against a wide range of COVID-19 variants and related coronaviruses, including past, present and potentially future strains.

The MRC director, Prof Moffat Nyirenda, said the study offers Ugandan scientists opportunities to showcase their capabilities ...

Vaxcyte's stock surges on promising vaccine data, offering potential upside despite competition. Learn more on PCVX here.